MedTrace Logo

Atropine in the Treatment of Myopia Study in Malaysia

NCT07329777 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2026-01-09

No results posted yet for this study

Summary

This clinical trial is designed to assess the efficacy and safety of Atropine Sulphate 0.025% w/v Eye Drops compared to placebo in a randomized, double-blind, placebo-controlled study for the management of myopia progression in children.

Conditions

  • Myopia Progression

Interventions

DRUG

Low dose atropine sulfate eye drops

Atropine Sulphate 0.025% w/v Eye Drops

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Singapore National Eye Centre

    collaborator OTHER_GOV

  • IDB VisionCare SDN BHD

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-17
Primary Completion
2027-09-30
Completion
2029-09-30

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07329777 on ClinicalTrials.gov